BioCentury
ARTICLE | Company News

FDA panel votes on EnteroMedics' VBLOC

June 18, 2014 12:50 AM UTC

FDA's Gastroenterology and Urology Devices Panel voted 6-2, with one abstention, that the relative benefits of the Maestro Rechargeable (RC) System from EnteroMedics Inc. (NASDAQ:ETRM) outweigh the risks to treat obesity. The system -- which is approved in Europe and Australia -- comprises the implantation of two electrodes that deliver intermittent electrical impulses to the vagus nerve, which affects the perception of hunger and fullness. ...